InsidersTradesSigma
Browse the complete record of transactions filed by Mansbach Harry H, Directeur Médical. Director active across 1 company, notably 89bio, Inc.. In total, 2 filings have been logged. Activity tracked since 17 February 2022. The latest transaction was filed on 5 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Harry H. Mansbach is the Chief Medical Officer at 89bio, Inc. In this role, he oversees clinical initiatives and product development strategies, focusing on innovation in the biopharmaceutical field. His medical expertise is essential for the company's success.